• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重药物皮肤反应的临床特征和预后因素。

Clinical features and prognostic factors in severe cutaneous drug reactions.

机构信息

Department of Internal Medicine, SMG-SNU Boramae Medical Center, Seoul, Republic of Korea.

出版信息

Int Arch Allergy Immunol. 2013;162(4):346-54. doi: 10.1159/000354918. Epub 2013 Oct 25.

DOI:10.1159/000354918
PMID:24193402
Abstract

BACKGROUND

Severe cutaneous adverse reactions (SCARs) include Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and drug reaction with eosinophilia and systemic symptoms (DRESS). SJS and TEN (SJS/TEN) and DRESS are thought to be different diseases; however, they share some clinical and laboratory features. Although SCORTEN serves as an excellent prognostic marker for SJS/TEN, there is still a need for development of other prognostic markers for SCARs.

METHODS

The study population consisted of 88 SCAR patients. Clinical characteristics and clinical manifestations were compared between SJS/TEN and DRESS. Risk factor analyses for prolonged hospitalization were performed.

RESULTS

Of the 88 patients, 41 were SJS/TEN and 47 were DRESS. Mortality rates of TEN and DRESS were 9.8 and 2.1%, respectively. Allopurinol and carbamazepine were the most common causes of both SJS/TEN and DRESS (34.7 and 62.9%, respectively). Some of the systemic presentations, such as fever and laboratory abnormalities were common in both phenotypes. Thrombocytopenia tended to be related to prolonged hospitalization (longer than 3 weeks) in SJS/TEN (odds ratio, OR = 5.1, 95% confidence interval, CI 0.8-31.8, p = 0.076). In DRESS patients, leukocytosis at presentation (OR 4.8, 95% CI 1.1-20.3, p = 0.03) was related to prolonged hospitalization.

CONCLUSIONS

Clinical features of SCARs in a tertiary hospital in Korea were similar to those reported previously. SJS/TEN and DRESS shared some clinical and laboratory features. Thrombocytopenia for SJS/TEN and leukocytosis at presentation for DRESS may be useful prognostic markers for prolonged hospitalization.

摘要

背景

严重皮肤不良反应(SCAR)包括史蒂文斯-约翰逊综合征(SJS)、中毒性表皮坏死松解症(TEN)和药物反应伴嗜酸性粒细胞增多和全身症状(DRESS)。SJS 和 TEN(SJS/TEN)和 DRESS 被认为是不同的疾病,但它们具有一些共同的临床和实验室特征。尽管 SCORTEN 是 SJS/TEN 的一个极好的预后标志物,但仍需要开发其他 SCAR 的预后标志物。

方法

研究人群包括 88 例 SCAR 患者。比较了 SJS/TEN 和 DRESS 之间的临床特征和临床表现。分析了导致住院时间延长的危险因素。

结果

88 例患者中,41 例为 SJS/TEN,47 例为 DRESS。TEN 和 DRESS 的死亡率分别为 9.8%和 2.1%。别嘌呤醇和卡马西平是 SJS/TEN 和 DRESS 的最常见原因(分别为 34.7%和 62.9%)。发热和实验室异常等一些全身表现在两种表型中都很常见。血小板减少倾向于与 SJS/TEN 的住院时间延长(超过 3 周)有关(比值比[OR]为 5.1,95%置信区间[CI]为 0.8-31.8,p=0.076)。在 DRESS 患者中,就诊时白细胞增多(OR 4.8,95%CI 1.1-20.3,p=0.03)与住院时间延长有关。

结论

韩国一家三级医院的 SCAR 临床特征与先前报道的相似。SJS/TEN 和 DRESS 具有一些共同的临床和实验室特征。SJS/TEN 的血小板减少和 DRESS 的就诊时白细胞增多可能是住院时间延长的有用预后标志物。

相似文献

1
Clinical features and prognostic factors in severe cutaneous drug reactions.严重药物皮肤反应的临床特征和预后因素。
Int Arch Allergy Immunol. 2013;162(4):346-54. doi: 10.1159/000354918. Epub 2013 Oct 25.
2
Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.HLA 与卡马西平诱导的过敏反应的基因型-表型关联:强度和临床相关性。
J Dermatol Sci. 2014 Feb;73(2):101-9. doi: 10.1016/j.jdermsci.2013.10.003. Epub 2013 Oct 22.
3
Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations.抗癫痫药物导致的史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症与药物诱导的超敏反应综合征具有某些共同的临床和实验室特征,尽管皮肤表现存在差异。
Clin Exp Dermatol. 2010 Oct;35(7):723-8. doi: 10.1111/j.1365-2230.2009.03718.x.
4
An epidemiological and clinical analysis of cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.马来西亚柔佛州一家 tertiary 医院的皮肤药物不良反应的流行病学和临床分析。
Indian J Dermatol Venereol Leprol. 2012 Nov-Dec;78(6):734-9. doi: 10.4103/0378-6323.102367.
5
HLA-B*58:01 is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome/toxic epidermal necrolysis in a Portuguese population.HLA-B*58:01 是葡萄牙人群中别嘌醇诱导的 DRESS 和 Stevens-Johnson 综合征/中毒性表皮坏死松解症的危险因素。
Br J Dermatol. 2013 Sep;169(3):660-5. doi: 10.1111/bjd.12389.
6
A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions.一项多中心研究,旨在确定药物斑贴试验在三种主要严重皮肤不良反应类别的价值和安全性。
Br J Dermatol. 2013 Mar;168(3):555-62. doi: 10.1111/bjd.12125.
7
Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.静脉注射免疫球蛋白与糖皮质激素联合治疗中毒性表皮坏死松解症和史蒂文斯-约翰逊综合征:中国的一项回顾性对照研究
Int J Dermatol. 2009 Oct;48(10):1122-8. doi: 10.1111/j.1365-4632.2009.04166.x.
8
Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS/TEN are different from those found for the same AED-induced DRESS in the Spanish population.与芳香族抗癫痫药物(AED)诱导的中毒性表皮坏死松解症(SJS/TEN)显著相关的HLA I类类型与西班牙人群中相同AED诱导的药物反应伴嗜酸性粒细胞增多和系统症状(DRESS)所发现的不同。
Pharmacol Res. 2017 Jan;115:168-178. doi: 10.1016/j.phrs.2016.11.027. Epub 2016 Nov 22.
9
Analysis of Individual Case Safety Reports of Severe Cutaneous Adverse Reactions in Korea.韩国严重皮肤不良反应的个体病例安全报告分析
Yonsei Med J. 2019 Feb;60(2):208-215. doi: 10.3349/ymj.2019.60.2.208.
10
Cicatrizing Conjunctivitis in a Patient Diagnosed With Drug Reaction With Eosinophilia and Systemic Symptoms/Drug-Induced Hypersensitivity Syndrome but With Features of Stevens-Johnson Syndrome.一名被诊断为药物反应伴嗜酸性粒细胞增多和全身症状/药物性超敏反应综合征但具有史蒂文斯-约翰逊综合征特征的患者出现的瘢痕性结膜炎
Cornea. 2016 Jun;35(6):888-91. doi: 10.1097/ICO.0000000000000845.

引用本文的文献

1
Role of neutrophil-lymphocyte ratio as a prognostic marker in SJS/TEN patients.中性粒细胞-淋巴细胞比值作为 SJS/TEN 患者预后标志物的作用。
Arch Dermatol Res. 2024 Aug 23;316(8):564. doi: 10.1007/s00403-024-03327-z.
2
Stevens-Johnson Syndrome From Combined Allopurinol and Angiotensin-Converting Enzyme Inhibitors: A Narrative Review.别嘌醇与血管紧张素转换酶抑制剂联用引发的史蒂文斯-约翰逊综合征:一项叙述性综述
Cureus. 2024 Jan 8;16(1):e51899. doi: 10.7759/cureus.51899. eCollection 2024 Jan.
3
DRESS, the maverick among SCARS: A case series-based review of literature.
DRESS,瘢痕性疾病中的异类:基于病例系列的文献综述
Med J Armed Forces India. 2023 May-Jun;79(3):328-336. doi: 10.1016/j.mjafi.2020.11.027. Epub 2021 Jun 28.
4
Drug allergy evaluation in children with suspected mild antibiotic allergy.疑似轻度抗生素过敏儿童的药物过敏评估
Front Allergy. 2022 Dec 5;3:1050048. doi: 10.3389/falgy.2022.1050048. eCollection 2022.
5
The Correlation of Neutrophil-Lymphocyte Ratio and Eosinophil Count with SCORTEN in SJS/TEN.中毒性表皮坏死松解症/史蒂文斯-约翰逊综合征中中性粒细胞与淋巴细胞比值及嗜酸性粒细胞计数与SCORTEN的相关性
Clin Cosmet Investig Dermatol. 2022 Mar 30;15:547-556. doi: 10.2147/CCID.S356450. eCollection 2022.
6
Clinical Features, Risk Factors, and Prognostic Markers of Drug-Induced Liver Injury in Patients with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症患者药物性肝损伤的临床特征、危险因素及预后标志物
Indian J Dermatol. 2020 Jul-Aug;65(4):274-278. doi: 10.4103/ijd.IJD_217_19.
7
Anti-MDA-5 Dermatomyositis With Development of Drug-Mediated Necrolytic Skin Lesions.抗 MDA-5 皮肌炎伴药物诱导性皮肤坏死性病变。
J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620940496. doi: 10.1177/2324709620940496.
8
Severe Cutaneous Adverse Reactions to Antiepileptic Drugs: A Nationwide Registry-Based Study in Korea.抗癫痫药物引起的严重皮肤不良反应:韩国一项基于全国登记系统的研究
Allergy Asthma Immunol Res. 2019 Sep;11(5):709-722. doi: 10.4168/aair.2019.11.5.709.
9
Analysis of Individual Case Safety Reports of Severe Cutaneous Adverse Reactions in Korea.韩国严重皮肤不良反应的个体病例安全报告分析
Yonsei Med J. 2019 Feb;60(2):208-215. doi: 10.3349/ymj.2019.60.2.208.
10
Markers of systemic involvement and death in hospitalized cancer patients with severe cutaneous adverse reactions.住院癌症患者严重皮肤不良反应的全身受累标志物和死亡。
J Am Acad Dermatol. 2019 Mar;80(3):608-616. doi: 10.1016/j.jaad.2018.10.039. Epub 2018 Oct 26.